Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, Non-Hodgkin
×
Standard of Care
×
1 year
×
Clear all
Filters
3
NCT03575351
2025-08-03
TRANSFORM
Celgene
Phase 3
Completed
184 enrolled
30 charts
1 FDA